HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Ogawa Selected Research

Leptin

3/2004Serum leptin level is a regulator of bone mass.
5/2003Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance.
7/2002Clinical implications of leptin and its potential humoral regulators in long-term low-calorie diet therapy for obese humans.
5/2002Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome.
4/2002Role of leptin in pregnancy--a review.
11/2001[Potential molecular targets for anti-obesity drugs--after the discovery of leptin].
6/2001Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes.
3/2001[Pathology and significance of leptin resistance in obesity].
3/2001[Human obesity and point mutations of leptin and leptin receptor].
5/2000Pathophysiological role of leptin in obesity-related hypertension.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Ogawa Research Topics

Disease

39Neoplasms (Cancer)
11/2020 - 01/2000
12Breast Neoplasms (Breast Cancer)
04/2017 - 01/2000
12Obesity
05/2003 - 02/2000
8Hypertension (High Blood Pressure)
06/2016 - 04/2000
8Dry Eye Syndromes (Dry Eye Syndrome)
11/2012 - 05/2001
8Body Weight (Weight, Body)
03/2004 - 07/2000
7Insulin Resistance
04/2002 - 02/2000
5Diabetes Mellitus
01/2019 - 09/2000
5Carcinoma (Carcinomatosis)
01/2018 - 01/2000
5Fibrosis (Cirrhosis)
07/2008 - 04/2000
5Infections
09/2003 - 01/2000
4Pain (Aches)
11/2015 - 05/2000
4Neoplasm Metastasis (Metastasis)
10/2014 - 01/2000
4Bronchiolitis Obliterans Syndrome
02/2008 - 01/2001
4Prostatic Neoplasms (Prostate Cancer)
01/2006 - 08/2001
4Stomach Ulcer (Gastric Ulcer)
01/2001 - 03/2000
4Adenocarcinoma
01/2001 - 01/2000
3Proteinuria
05/2019 - 03/2000
3Renal Cell Carcinoma (Grawitz Tumor)
07/2015 - 01/2000
3Diabetic Nephropathies (Diabetic Nephropathy)
08/2012 - 10/2006
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2009 - 06/2001
3Inflammation (Inflammations)
02/2008 - 02/2001
3Disease Progression
09/2003 - 04/2001
3Fatty Liver
12/2001 - 11/2000
3Myocardial Infarction
08/2001 - 04/2000
3Adenoma (Adenomas)
04/2001 - 01/2000
3Spasm (Spasms)
09/2000 - 05/2000
2Osteoporosis
11/2020 - 09/2001
2Atherosclerosis
11/2020 - 05/2000
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2019 - 03/2006
2Melanoma (Melanoma, Malignant)
01/2019 - 01/2018
2Pneumonia (Pneumonitis)
01/2018 - 08/2007
2Urolithiasis
06/2016 - 01/2000
2Hyperlipidemias (Hyperlipidemia)
06/2016 - 12/2001
2Skin Diseases (Skin Disease)
03/2010 - 06/2001
2Contracture
08/2006 - 05/2001
2Obstructive Sleep Apnea
12/2003 - 05/2002
2Glucose Intolerance
05/2003 - 02/2000
2Ulcerative Colitis
07/2002 - 03/2000

Drug/Important Bio-Agent (IBA)

13LeptinIBA
03/2004 - 02/2000
7Insulin (Novolin)FDA Link
01/2019 - 02/2000
6AntibodiesIBA
01/2018 - 04/2000
6EnzymesIBA
02/2007 - 01/2000
6Glucose (Dextrose)FDA LinkGeneric
04/2002 - 02/2000
5Hormones (Hormone)IBA
05/2002 - 03/2000
5InterleukinsIBA
02/2001 - 03/2000
4AntigensIBA
01/2019 - 09/2000
4Pharmaceutical PreparationsIBA
01/2018 - 10/2000
4LectinsIBA
01/2017 - 09/2001
4Peptides (Polypeptides)IBA
07/2008 - 05/2000
4OxalatesIBA
02/2007 - 01/2000
4Therapeutic UsesIBA
08/2004 - 09/2000
4Hypoglycemic Agents (Hypoglycemics)IBA
05/2003 - 02/2000
3GlucocorticoidsIBA
05/2019 - 02/2000
3Prednisolone (Predate)FDA LinkGeneric
01/2019 - 03/2000
3Ribonucleases (Ribonuclease)IBA
02/2014 - 09/2001
3N-Acetylneuraminic Acid (Sialic Acid)IBA
02/2014 - 09/2001
3AcidsIBA
03/2010 - 01/2001
3Messenger RNA (mRNA)IBA
02/2008 - 01/2000
3Indicators and Reagents (Reagents)IBA
11/2007 - 02/2000
3Proteins (Proteins, Gene)FDA Link
03/2006 - 07/2000
3SolutionsIBA
07/2002 - 09/2000
3HDL CholesterolIBA
12/2001 - 07/2000
3Triglycerides (Triacylglycerol)IBA
12/2001 - 06/2001
3CholesterolIBA
12/2001 - 12/2000
3Indomethacin (Indometacin)FDA LinkGeneric
10/2001 - 01/2001
3Interleukin-8 (Interleukin 8)IBA
02/2001 - 04/2000
3Immunoglobulin G (IgG)IBA
01/2001 - 04/2000
3TamoxifenFDA LinkGeneric
12/2000 - 05/2000
3Calcium OxalateIBA
10/2000 - 01/2000
2NivolumabIBA
01/2019 - 01/2018
2Monoclonal AntibodiesIBA
01/2018 - 07/2000
2Toll-Like Receptor 4IBA
08/2012 - 08/2007
2Transforming Growth Factor beta (TGF-beta)IBA
03/2010 - 08/2000
2LipidsIBA
01/2009 - 12/2001
2Adrenal Cortex Hormones (Corticosteroids)IBA
08/2008 - 05/2001
2Ophthalmic Solutions (Eye Drops)IBA
08/2008 - 04/2003
2Connective Tissue Growth FactorIBA
07/2008 - 02/2008
2Brain Natriuretic Peptide (Natrecor)FDA Link
10/2006 - 04/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2005 - 01/2001
2propionic acid (potassium propionate)IBA
03/2005 - 10/2001
2antigen CYFRA21.1IBA
08/2004 - 09/2000
2Carcinoembryonic AntigenIBA
08/2004 - 09/2000
2Interferon-gamma (Interferon, gamma)IBA
11/2002 - 03/2000
2Superoxide DismutaseIBA
07/2002 - 08/2001
2Dihydrotachysterol (AT 10)IBA
07/2002 - 09/2000

Therapy/Procedure

14Therapeutics
01/2019 - 10/2000
7Hematopoietic Stem Cell Transplantation
01/2017 - 01/2001
5Radiotherapy
07/2001 - 01/2000
4Cautery
11/2012 - 01/2001
4Drug Therapy (Chemotherapy)
01/2001 - 01/2000
3Aftercare (After-Treatment)
05/2019 - 09/2000
3Immunotherapy
04/2017 - 12/2000
3Nephrectomy
07/2015 - 04/2000
3Kidney Transplantation
07/2015 - 07/2001
3Lasers (Laser)
01/2014 - 05/2010
3Stem Cell Transplantation
01/2009 - 04/2003
3Segmental Mastectomy (Lumpectomy)
11/2000 - 01/2000
2Transplantation
07/2015 - 09/2002
2Punctal Plugs
11/2012 - 04/2003